These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 20016423

  • 1. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy.
    Tempelhof MW.
    South Med J; 2009 Dec; 102(12):1201-2. PubMed ID: 20016423
    [No Abstract] [Full Text] [Related]

  • 2. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ, Smith SM, Choksi R.
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [Abstract] [Full Text] [Related]

  • 3. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M.
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract] [Full Text] [Related]

  • 4. Renin-angiotensin system blocking drugs.
    Robles NR, Cerezo I, Hernandez-Gallego R.
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [Abstract] [Full Text] [Related]

  • 5. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V, Buksa M, Loza V, Kulic M.
    Med Arh; 2009 Jan; 63(6):343-9. PubMed ID: 20380117
    [Abstract] [Full Text] [Related]

  • 6. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
    Weber MA, Giles TD.
    Rev Cardiovasc Med; 2006 Jan; 7(2):45-54. PubMed ID: 16915123
    [Abstract] [Full Text] [Related]

  • 7. Direct inhibition of renin: a physiological approach to treat hypertension and cardiovascular disease.
    Ram CV.
    Future Cardiol; 2009 Sep; 5(5):453-65. PubMed ID: 19715410
    [Abstract] [Full Text] [Related]

  • 8. [The future of renin inhibition].
    Uresin AY, Baran E.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [Abstract] [Full Text] [Related]

  • 9. Complete inhibition of the renin-angiotensin-aldosterone system; where do we stand?
    Chen SS, Seliger SL, Fried LF.
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):449-55. PubMed ID: 25014549
    [Abstract] [Full Text] [Related]

  • 10. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F, Krzesinski JM, Piérard L, Scheen AJ.
    Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
    [Abstract] [Full Text] [Related]

  • 11. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G.
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract] [Full Text] [Related]

  • 12. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
    Horký K.
    Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
    [Abstract] [Full Text] [Related]

  • 13. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 14. Aliskiren: a new inhibitor of renin-angiotensin aldosterone system activity.
    Dalla Vestra M, Simioni N, Masiero A.
    Minerva Endocrinol; 2009 Dec; 34(4):333-8. PubMed ID: 20046162
    [Abstract] [Full Text] [Related]

  • 15. What is the role of direct renin inhibitors in the treatment of the hypertensive diabetic patient?
    de la Sierra A, Salazar J.
    Adv Ther; 2011 Sep; 28(9):716-27. PubMed ID: 21809181
    [Abstract] [Full Text] [Related]

  • 16. Renin inhibition--benefit beyond hypertension control.
    Kher V.
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [Abstract] [Full Text] [Related]

  • 17. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
    Probstfield J.
    J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
    [No Abstract] [Full Text] [Related]

  • 18. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT.
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract] [Full Text] [Related]

  • 19. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P, Gentile G, Angeli F, Reboldi G.
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.